Welcome to Mediso

Please select your region:

North America
Europe
Rest of the World

Please select your language:

Go

Mediso receives FDA approval for InterView™ software

Mediso has announced the Food and Drug Administration (FDA) clearance of the InterView™ FUSION and InterView™ XP multimodality (PET/SPECT/MRI/CT) image processing and reporting software which is specifically adapted for nuclear medicine and molecular imaging workflows.

Explore
Mediso receives FDA approval for InterView™ software
Explore
Mediso receives FDA approval for InterView™ software

Mediso installs 100% cryogen-free 7T MRI

Mediso Medical Imaging Systems recently installed a state-of-the-art 7T MRI at the University of Milano-Bicocca.

Explore
Mediso installs 100% cryogen-free 7T MRI
Explore
Mediso installs 100% cryogen-free 7T MRI

nanoScan® SPECT/CT

Versatile SPECT/CT with absolute quantification and full stationary dynamic imaging

Explore
nanoScan® SPECT/CT
Explore
nanoScan® SPECT/CT

Products suited for your business

Preclinical products

The equipment of Mediso nanoScan® Family deliver the current and future promise of molecular imaging by maximizing functional information in combination with precise anatomical detail.

nanoScan® PET/MRI 3T and 7T
nanoScan® PET/MRI 3T and 7T

Full-scale, quantitative PET combined with a robust, cryogen-free MRI

View product
nanoScan® SPECT/CT
nanoScan® SPECT/CT

Versatile SPECT/CT with absolute quantification and full stationary dynamic imag...

View product
nanoScan® PET/CT
nanoScan® PET/CT

Real dynamic PET-system designed for quantitative studies

View product
All Preclinical products
Explore
Explore all products

Latest news & events

2024.12.05. - 2024.12.08.

SNMICON 2024

India (SNM-India) was founded in 1967 with the aim to promote, encourage and help the development and advancement of Nuclear Medicine as a specialty i...
View event
2024.09.15. - 2024.09.19.

IMAGING IN 20/20 IN 2024

We are pleased to Sponsor the Imaging in 20/20 meeting in 2024 again. "Imaging in 20/20 was created in 1999 to advance the emerging field of molecula...
View event
2024.09.09. - 2024.09.13.

WMIC 2024

The World Molecular Imaging Congress brings together people from across the globe who represent the entire spectrum of Molecular Imaging. These indivi...
View event
All news & events

About us

Since 1990, Mediso is creating new technologies, and molecular imaging systems.

Clinical and pre-clinical solutions for hospitals, clinics and scientific institution

  • 1943

    George Hevesy received Nobel Prize for nuclear tracer theory

  • 1972

    Gamma Works released its first NM imager with digital processing

  • 1990

    Foundation of Mediso

  • 1994

    Introduction of the first Mediso gamma camera

  • 1996

    Release of the first SPECT camera Nucline™ X-Ring-R

  • 1998

    Mediso acquired the NM profile of Gamma Works

  • 2000

    Launch of the Nucline™ SPIRIT DH-V variable angle dual head camera

  • 2002

    Nucline X-ring/4R, 4-head dedicated brain SPECT

  • 2005

    Establishing Mediso Gmbh in Munster, Germany

  • 2006

    Launching the first Mediso preclinical system the nanoSPECT/CT

  • 2007

    Production of the first Mediso clinical SPECT/CT. Mediso takes on NM clinical diagnostic service profile acquiring ScanoMed Ltd.

  • 2008

    Launch of AnyScan® multimodality clinical imaging family

  • 2010

    Launch of nanoScan® PET/CT, world’s first ever sub-mm resolution preclinical PET/CT

  • 2012

    Introduction of the nanoScan® PET/MRI 1T, world’s first ever commercial preclinical PET/MRI

  • 2013

    Establishing Mediso USA in Boston, MA

  • 2014

    MultiScan™ LFER 150, world’s first sub-mm resolution portable PET/CT

  • 2015

    AnyScan® TRIO SPECT, introduction of triple SPECT detector family

  • 2016

    Opening of new HQ in Budapest, Hungary

  • 2016

    Introducing the nanoScan® PET/MRI 3T world’s first superconducting preclinical PET/MRI

Learn more

How can we help you?

Don't hesitate to contact us for technical information or to find out more about our products and services.

Get in touch